IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v8y2024i4d10.1007_s41669-024-00488-5.html
   My bibliography  Save this article

Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France

Author

Listed:
  • Gérard Pouvourville

    (Essec Business School)

  • Manon Breau-Brunel

    (Amaris Consulting)

  • Véronique Loncle-Provot

    (GSK)

  • Ekkehard Beck

    (GSK)

  • Loïg Gaugain

    (Amaris Consulting)

  • Gaëlle Nachbaur

    (GSK)

  • Céline Pribil

    (GSK)

Abstract

Background and Objectives In France, meningococcal serogroup B (MenB) is the most common serogroup causing invasive meningococcal disease (IMD) in infants and young children. Our objective was to illustrate the impact of model choices on health outcomes and the cost-effectiveness of infant vaccination with the multicomponent meningococcal serogroup B vaccine (4CMenB) versus no vaccine in France. Methods A previously published dynamic transmission-based cost-effectiveness model was adapted for the French context using updated, French-specific demographic, epidemiological, and cost data. IMD incidence and long-term sequelae were derived through analysis of French healthcare and surveillance databases. A collective perspective over a 100-year time horizon was adopted, with a discount rate of 2.5%, reduced to 1.5% after the first 30 years. Deterministic and probabilistic sensitivity and scenario analyses were performed. Results In the base case analysis, infant vaccination with 4CMenB avoided 3101 MenB IMD cases in infants aged

Suggested Citation

  • Gérard Pouvourville & Manon Breau-Brunel & Véronique Loncle-Provot & Ekkehard Beck & Loïg Gaugain & Gaëlle Nachbaur & Céline Pribil, 2024. "Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France," PharmacoEconomics - Open, Springer, vol. 8(4), pages 539-557, July.
    • Handle: RePEc:spr:pharmo:v:8:y:2024:i:4:d:10.1007_s41669-024-00488-5
    DOI: 10.1007/s41669-024-00488-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-024-00488-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-024-00488-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:8:y:2024:i:4:d:10.1007_s41669-024-00488-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.